Quest Diagnostics Incorporated (DGX)

Quest Diagnostics has recently reported quarterly results and updated investors on trends in diagnostic testing demand. What drives the stock now, and which revenue streams are key for US-focused shareholders?

Form 4 shows Quest Diagnostics director Timothy M. Ring granted 1,142 restricted stock units, lifting his direct holdings to 31,140 shares, including dividend reinvestment.

Phibro Animal Health, carrying ... Its earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 16.3%. PAHC shares have rallied 41.8% against the industry’s 32.8% decline over the past year. Want the latest recommendations from Zacks Inve…

Incremental sales over the last five years were much less profitable as its earnings per share fell by 6.2% annually while its revenue grew · Quest’s stock price of $194.03 implies a valuation ratio of 17.7x forward P/E. To fully understand why you should be careful with DGX, check out our ...

Following the last earnings report on Mar 31, 2026, DGXX's stock price moved — from — to —.